VECTIBIX

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug VECTIBIX contains one active pharmaceutical ingredient (API):

1 Panitumumab UNII 6A901E312A - PANITUMUMAB

Panitumumab is a recombinant, fully human IgG2 monoclonal antibody that binds with high affinity and specificity to the human EGFR. Panitumumab binds to the ligand binding domain of EGFR and inhibits receptor autophosphorylation induced by all known EGFR ligands. Binding of panitumumab to EGFR results in internalisation of the receptor, inhibition of cell growth, induction of apoptosis, and decreased interleukin 8 and vascular endothelial growth factor production. Read about Panitumumab

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
VECTIBIX Concentrate for solution for infusion	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01FE02	Panitumumab	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01F Monoclonal antibodies and antibody drug conjugates → L01FE EGFR (Epidermal Growth Factor Receptor) inhibitors
Discover more medicines within L01FE02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10069Y, 10082P, 10508C, 10513H
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 544115070000317, 544115070000417
Country: CA	Health Products and Food Branch	Identifier(s): 02308487, 02308509
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): H6200713
Country: EE	Ravimiamet	Identifier(s): 1342279, 1342280, 1342291
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 07423001, 07423003
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 119031, 119053
Country: FR	Base de données publique des médicaments	Identifier(s): 66403621
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 130945, 146891
Country: HK	Department of Health Drug Office	Identifier(s): 61371
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6331
Country: IT	Agenzia del Farmaco	Identifier(s): 038347011, 038347035
Country: JP	医薬品医療機器総合機構	Identifier(s): 4291417A1020, 4291417A2027
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1031148, 1031150
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 85812, 87459
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100027929
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W52724001, W52724003
Country: SG	Health Sciences Authority	Identifier(s): 14498P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699862760010, 8699862760027
Country: US	FDA, National Drug Code	Identifier(s): 55513-954, 55513-956
Country: ZA	Health Products Regulatory Authority	Identifier(s): 44/30.1/0110, 44/30.1/0111, 44/30.1/0112